title: [Treatment of atrial fibrillation - status quo].
authors.affiliation: Klinikum Bogenhausen, Herzzentrum München-Bogenhausen, Klinik für Kardiologie und internistische Intensivmedizin, Städtisches Klinikum München GmbH. florian.straube@klinikum-muenchen.de
authors.forename: F
authors.initials: F
authors.lastname: Straube
authors.forename: U
authors.initials: U
authors.lastname: Dorwarth
authors.forename: M
authors.initials: M
authors.lastname: Schmidt
authors.forename: E
authors.initials: E
authors.lastname: Hoffmann
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000627:therapeutic use; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications / Q000209:etiology / Q000628:therapy*; D017115:Catheter Ablation / Q000379:methods; D002986:Clinical Trials as Topic; D005500:Follow-Up Studies; D006325:Heart Atria / Q000601:surgery; D006801:Humans; D019736:Prostheses and Implants; D020521:Stroke / Q000517:prevention & control; D013923:Thromboembolism / Q000517:prevention & control; D016896:Treatment Outcome; D014812:Vitamin K / Q000037:antagonists & inhibitors
chemical_list: D000889:Anti-Arrhythmia Agents; D000925:Anticoagulants; D014812:Vitamin K